More than 240 companies across the globe claim to have the required capabilities to offer variety of

Owing to various reasons, such as growing manufacturing demand, need for specialized facilities, equipment and operational expertise, and high costs of development associated with certain drugs / therapies, a number of ophthalmic drug developers have demonstrated a preference to outsource certain aspects of drug development and production operations to contract service providers.

To order this 375+ page report, which features 180+ figures and 195+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/ophthalmic-drugs-cmo/294.html

The USD 1.7 billion financial opportunity (by 2030) within the ophthalmic drugs contract manufacturing market has been analyzed across the following segments:

Type of product

Ophthalmic APIOphthalmic drug FDFType of FDF manufacturedSolidSemi-solidLiquid / suspension

Type of primary packaging

Ampoule / vial 

Glass / plastic bottle

Ointment tube

Blister packing

Other forms

Scale of manufacturing

ClinicalCommercial

Company size

SmallMid-sizedLargeVery large

Target disease indication

Age-related macular degenerationDry eyeGlaucomaOther disease segments

Key geographical regions

North America (US, Canada and Mexico)Europe (UK, Germany, France, Spain, Italy and rest of Europe)Asia-Pacific (India, China, Japan, Australia and rest of Asia-Pacific)Rest of the world

The Ophthalmic Drugs Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms (Ophthalmic Drops, Emulsions, Gels, Injections, Lotions, Ointments, Suspensions, and Tablets / Capsules), 2020-2030.” report features the following companies, which we identified to be key players in this domain: 

AkornAkumsBal PharmaCatalentCayman ChemicalEntod PharmaceuticalsFarmigeaGlenmark PharmaceuticalsIndiana OphthalmicsLomapharmMedichemPillar5 PharmaRecipharmSalvatSterling Pharmaceutical ServicesSunways India

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Current Market Landscape

5. Company Competitiveness Analysis

6. Ophthalmic Drugs Contract Manufacturing in North America: Company Profiles

7. Ophthalmic Drugs Contract Manufacturing in Europe: Company Profiles

8. Ophthalmic Drugs Contract Manufacturing in Asia-Pacific: Company Profiles

9. Clinical Trial Analysis

10. Capacity Analysis

11. Demand Analysis

12. Market Forecast

13. Case Study: Comparison of Small Molecule and Large Molecule Ophthalmic Drugs / Therapies

14. SWOT Analysis

15. Survey Analysis

 

16. Executive Insights

 

17. Future Growth Opportunities

 

18. Appendix 1: List of Ophthalmic Medical Device Contract Manufacturers

19. Appendix 2: Tabulated Data

20. Appendix 3: List of Companies and Organizations

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/ophthalmic-drugs-cmo/294.html

Contact:

Gaurav Chaudhary

+1 (415) 800 3415

+44 (122) 391 1091

[email protected]